At a post-translational level, a phosphorylation of RKIP at Serine 153 (pSer153-RKIP) by protein kinase C ζ (PKCζ) has been found in several cancer types to account for loss of RKIP activity as a Raf-1 proto-oncogene, serine/threonine kinase/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (Raf/MEK/ERK) and GPCR inhibitor, through inhibition of G protein-coupled receptor kinase 2(GRK2) [6,30,74,75,76,77,78]. The gene discussed is MAPK1; the disease is cancer.